AgeX Therapeutics, Inc. (AGE)

R&D Expense Growth

19.29%

Quarterly · Period ending:

AGE logo

AGE R&D Expense Growth

Latest reported19.29%
AGE Quarterly R&D Growth (QoQ) (0.00% → 19.29%)
High-resolution chart · PNG

AGE r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

AgeX Therapeutics, Inc. R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
19.2873%
-5.9394%
-6.8474%
15.8312%
6.8113%
-50.874%
148.7371%
51.5056%
44.123%
642.2819%
-31.6514%
36.25%
-8.046%
-16.3462%
28.3951%
-37.4517%
-34.596%
5.3191%
36.7273%
-42.8274%
48.4568%
-72.6813%
41.3588%
-37.8519%
-15.7829%
9.1219%
1.5204%
-12.303%
23.3184%
-12.1471%
14.3393%
-3.7572%
-42.1163%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.